<DOC>
	<DOCNO>NCT00565669</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Blink Tears Systane use concomitantly topical cyclosporine treatment dry eye .</brief_summary>
	<brief_title>Evaluation Blink Tears Systane Concomitant With Restasis Treatment Dry Eye Symptoms</brief_title>
	<detailed_description>Dry eye chronic condition believe afflict 3 million patient United States.1 Symptoms dry eye bothersome impact quality life , reduce work capacity , may result poor psychological health . Also , symptom dry eye associate decreased ability perform activity require visual attention read drive car.2 Patients dry eye complain frequently scratchy sandy ( foreign body ) sensation . Other common symptom itch , excessive mucus secretion , inability produce tear , burn sensation , photosensitivity , redness , pain , difficulty move lid . In patient , remarkable feature eye examination grossly normal appearance eye.3 Chronic dry eye disease associate inflammatory mechanism mediate activate T-cell lymphocytes3 affect ocular surface lacrimal gland.4 The damage cause dry eye disease may irreversible , despite availability various tear substitute , many patient dry eye syndrome experience corneal injury subsequent reduction vision.5 Cyclosporin A ( Restasis® , Allergan , Irvine , CA ) show significantly reduce number activate T-lymphocytes within conjunctiva6 , thereby minimize inflammation cause dry eye . Topical cyclosporin A 0.05 % ophthalmic emulsion ( Restasis® , Allergan , Irvine , CA ) increase tear production improve quality naturally produce tear first approve therapeutic agent treatment chronic dry eye treatment modality address underlie pathology . In addition topical therapy cyclosporine , patient continue use artificial tear occasional relief residual symptom . The choice concomitant tear important little research publish differentiate efficacy solution use concomitantly topical cyclosporine .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>1 . Subject must dry eye . 2 . Age : 18 year old . 3 . Males females 4 . Up grade 3 conjunctival staining . 5 . Score 4 Subjective Evaluation Symptoms Dryness ( SESOD ) screening . 6 . Currently use Restasis treat dry eye syndrome ( least 3 month prior enrollment ) . 7 . Willing able comply schedule visit study procedure . 1 . Prior unsuccessful use topical cyclosporine ( defined patient take least 3 month without improvement . 2 . Known contraindication study medication ingredient . 3 . Planned use contact lens ( unless discontinue use 30 day prior randomization . 4 . Contact lens use active treatment portion trial . 5 . Active ocular allergy . 6 . Ocular surgery within past 3 month . 7 . Any concurrent infectious/non infectious conjunctivitis , keratitis uveitis . 8 . Active ocular disease uncontrolled systemic disease ( blepharitis patient actively treat disease uncontrollable . 9 . Pregnant nursing mother females childbearing potential practicing reliable medically acceptable method birth control . 10 . Participation ( current participation ) investigational drug device trial . 11 . Conjuctival stain grade 4 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Treatment</keyword>
	<keyword>Dry Eye</keyword>
</DOC>